Skip to main content
Explore URMC

menu

Genetic Testing in Screening Patients With Stage IB-IIIA Non-Small Cell Lung Cancer That Has Been or Will Be Removed by Surgery (The ALCHEMIST Screening Trial)

Research Question:
Does studying the genes in a patient's tumor help doctors select the best treatment for patients with non-small lung cancer?

Basic Study Information

Purpose:
This phase III ALCHEMIST trial studies genetic testing in screening patients with stage IB-IIIA non-small cell lung cancer that has been or will be removed by surgery. Studying the genes in a patient's tumor cells may help doctors select the best treatment for patients that have certain genetic changes.

Location: Highland Hospital

Study Contact Information

Study Coordinator: Site Public Contact
Phone: (585) 341-8113

Additional Study Details

Contact This Study

This field is required
This field is required
You must agree to be contacted to continue.

Return to Search